Hester Biosciences Limited (BOM:524669)
2,409.90
+13.15 (0.55%)
At close: Jul 15, 2026
Hester Biosciences Revenue
In the fiscal year ending March 31, 2026, Hester Biosciences had annual revenue of 3.34B INR with 6.93% growth. Hester Biosciences had revenue of 1.02B in the quarter ending March 31, 2026, with 40.33% growth.
Revenue
3.34B
Revenue Growth
+6.93%
P/S Ratio
6.20
Revenue / Employee
6.92M
Employees
483
Market Cap
20.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.34B | 216.47M | 6.93% |
| Mar 31, 2025 | 3.12B | 12.80M | 0.41% |
| Mar 31, 2024 | 3.11B | 329.89M | 11.86% |
| Mar 31, 2023 | 2.78B | 315.58M | 12.79% |
| Mar 31, 2022 | 2.47B | 289.51M | 13.30% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mukand | 48.90B |
| Nilkamal | 37.78B |
| Jay Bharat Maruti | 25.51B |
| Thirumalai Chemicals | 17.36B |
| Simplex Infrastructures | 10.21B |
| Nucleus Software Exports | 8.76B |
| SBC Exports | 4.03B |
| La Opala RG | 3.09B |
Hester Biosciences News
- 5 months ago - Hester Biosciences Q3 PAT jumps 140% to Rs 10.67cr - The Times of India
- 1 year ago - Hester Biosciences shares rally 15% as Q1 profit soars 131% YoY to Rs 17.3 crore, revenue rises 2% - Business Upturn
- 1 year ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 1 year ago - Hester Biosciences shares surge over 11% following strong Q2 FY25 performance - Business Upturn
- 1 year ago - Hester Biosciences Q2: Revenue jumps 18.8% YoY to ₹83.69 crores, PAT surges 107.4% YoY to ₹8.39 crores - Business Upturn